Suppliers / Gador S A

Gador S A

Argentina 3 duplicate records merged Updated 9 July 2026

Gador S A is a finished-dose manufacturer based in Argentina. It holds 4 active US drug master files across a filed portfolio of 3 molecules. Its filings concentrate with ANMAT (AR), ARCSA (EC) and ISP (CL). Its GMP standing is certified by EMA. Its most recent recorded inspection, by US FDA, closed on 3 August 2018 as VAI.

4
active US DMFs
0
valid CEPs
4
registered plants 1 with an FDA FEI number
218
filings across 8 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
3 of 3 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 3 August 2018 VAI US FDA
  • 22 May 2014 NAI US FDA
  • 26 May 2011 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Argentina, Argentina 3003276678
Pilar, Argentina Not on file
Buenos Aires, Argentina Not on file
BELO HORIZONTE, Brazil Not on file

What they file, and where

Molecule Regulators Docs
Pamidronic Acid US FDA 2
Norgestimate US FDA 1
Zoledronic Acid US FDA 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
ANMAT (AR) 98 None
ARCSA (EC) 55 None
ISP (CL) 28 None
DIGEMAPS (DO) 15 None
INVIMA (CO) 9 None
MINSA (CR) 7 None
EMA None 1

Comparing suppliers?

Choose your molecules and target markets. Gador S A comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 3 August 2018.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates